Post by Tony Crispino on Jun 7, 2014 17:33:01 GMT -8
Dr. Nicholas J. Vogelzang, one of the authors of the CHAARTED, Sweeney et al, clinical trial showing big benefits for men with oglio-mets or visceral prostate cancer will do a webinar at the UsTOO Las Vegas support group meeting on June 18 at 7:00pm Pacific Standard Time. I have a limited number of seats to perhaps the very first chance to ask a major CHAARTED researcher questions about the trial.
25 seats are available. I will consider opening more seats but at this time that's what open.
I will work tonight on the webinar and open it up for registration asap. I was not expecting this wonderful opportunity but this is a PCAF/UsTOO Las Vegas effort and Q&A's will be open for this fantastic physician over the two hour period.
PCAF will be announcing it's official opening on June 18. Of course we've been online since December but this is what we intend this website to be about. Facing the medical community researchers and opening up the ability to have these sessions with the industries very best! Next month we will have Dr. Brian Lawenda, a Harvard trained radiation oncologist and Stanford/UCLA trained accupuncturist present on integrative oncology.
Stay tuned and stay close. PCAF is helping you become your own best advocate!
About CHAARTED:
CHAARTED means: Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
Abstract:
abstracts.asco.org/144/AbstView_144_127755.html
25 seats are available. I will consider opening more seats but at this time that's what open.
I will work tonight on the webinar and open it up for registration asap. I was not expecting this wonderful opportunity but this is a PCAF/UsTOO Las Vegas effort and Q&A's will be open for this fantastic physician over the two hour period.
PCAF will be announcing it's official opening on June 18. Of course we've been online since December but this is what we intend this website to be about. Facing the medical community researchers and opening up the ability to have these sessions with the industries very best! Next month we will have Dr. Brian Lawenda, a Harvard trained radiation oncologist and Stanford/UCLA trained accupuncturist present on integrative oncology.
Stay tuned and stay close. PCAF is helping you become your own best advocate!
About CHAARTED:
CHAARTED means: Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial.
Abstract:
abstracts.asco.org/144/AbstView_144_127755.html
